BridgeMD
New treatment option for Effect of Skin to Skin Care in Preterm Neonates
Official title Immediate Skin-To-Skin Care For Preterm Infants After Birth
ClinicalTrials.gov ID: NCT06794164
What this study is testing
- What it's testing
- The standard procedure in our centre for preterm neonates is to enable skin-to-skin (SSC) contact within 24 hours after birth. As early SSC immediately after birth might provide numerous positive effects for mothers and their preterm neonates, the objective of this study is to evaluate the feasibility, the safety and the effect of skin-to-skin contact immediately after birth in preterm neonates born with gestational age between 26+0 and 32+0 weeks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 30
You may be able to join if
- Gestational age between 26+0 and 32+0 weeks
- Written parental informed consent
You likely can't join if
- No intention of full life support
- Severe congenital malformation
The study team makes the final eligibility decision.
Where it's taking place
- Graz, Styria, Austria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 minutes to 30 minutes. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Graz, Styria, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.